NeuroGrafix Statement on US Patent 5,560,360
At this time, NeuroGrafix advises & reminds users of MR Neurography, Diffusion Tensor Imaging (DTI, HARDI, and Q-Ball), or Diffusion Subtraction Neurography that they may be liable for having infringed US Patent 5,560,360 and its foreign equivalents. The issue arises if they are in the US, Japan, Europe, Canada or Australia, and if neither they nor their MRI manufacturer had a license....
Read MoreNeuroGrafix Statement on Siemens Litigation
NeuroGrafix makes the following agreed announcement effective today November 22, 2011: “The NeuroGrafix patent litigation against Siemens was dismissed in November 2011 pursuant to a confidential Settlement Agreement and Mutual Release. Pursuant to that agreement, Siemens obtained a license for itself and its customers.”
Read More